Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey
JCO Precision Oncology2023Vol. 7(7), pp. e2300440–e2300440
Citations Over TimeTop 19% of 2023 papers
Linda Rodgers, Sanjeevani Arora, Charité Ricker, Dan Li, Maheen Farooqi, Francesc Balaguer, Mev Dominguez–Valentin, José G. Guillem, Priyanka Kanth, David Liska, Joshua Melson, Kathryn A. Mraz, Brian H. Shirts, Eduardo Vilar, Bryson W. Katona, Rachel Hodan
Abstract
This study demonstrates wide support among hereditary GI cancer experts for implementation of UGT for patients with CRC. However, alternative service delivery models using nongenetics providers should be considered to address the logistical barriers to UGT implementation, particularly the growing demand for genetic testing.
Related Papers
- → Parental Attitudes toward Genetic Testing for Pediatric Deafness(2000)134 cited
- → Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing(2016)24 cited
- → Perception of genetic testing among patients with inherited retinal disease: Benefits and challenges in a Japanese population(2022)3 cited
- → Uptake of genetic testing among patients seeking cancer genetic counseling in Taiwan(2023)1 cited
- → Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single‐country, multi‐center, patient‐reported outcome study(2023)2 cited